HealthCor Partners Management, L.P. (HealthCor Partners), is a registered investment advisor with the U.S. Securities and Exchange
HealthCor Partners Management, L.P. ("HealthCor Partners"), is a registered investment advisor with the U.S. Securities and Exchange Commission (the “SEC”). Together with its affiliate, HealthCor Partners has approximately $365 million of capital commitments dedicated to private equity investments. HealthCor Partners invests primarily in growth equity and later stage developmental companies across all sectors of the healthcare and life sciences industry.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 5, 2022
Karyopharm Therapeutics
|
Post-IPO Equity | $165M | Health Care | — |
Oct 23, 2017
Claret Medical
|
Series C | $14.50M | Health Care | — |
Apr 6, 2015
Natera
|
Series F | $55.50M | Biotechnology | — |
Jan 1, 2008
HeartFlow
|
Seed | — | Artificial Intelligence | — |